Newsroom
Company news, product launches and press coverage from EClinCloud.
EClinCloud and Pure Global Form Strategic Partnership to Reshape End-to-End Clinical Research and Global Access with AIEClinCloud and Pure Global announce a strategic partnership.
Breaking New Ground in Clinical Trial Digitalization and Intelligence with AI: EClinCloud Opens a New Era in Clinical ResearchAs the lifeline of pharmaceutical AI, changes in algorithms and models have long drawn close industry attention.
EClinCloud Invites You to the 2025 CMAC Annual Conference to Discuss AI + eCOA Enabling Clinical TrialsOn 2025-03-10, EClinCloud published "EClinCloud Invites You to the 2025 CMAC Annual Conference to Discuss AI + eCOA Enabling Clinical Trials." See the full article below for the text and images.
AI-Driven, Shaping an Intelligent Future! EClinCloud's 5th Anniversary Annual Meeting Concludes SuccessfullyEClinCloud published "AI-Driven, Shaping an Intelligent Future! EClinCloud's 5th Anniversary Annual Meeting Concludes Successfully" on 2025-02-24. See the full text and images below.
Ranked #1: EClinCloud's Self-Trained AI Model Holds First Place in Alibaba Cloud Benchmark CompetitionIn the Alibaba Cloud Tianchi Lab benchmark competition, EClinCloud's self-trained AI model—the EDC OCR element extraction model—holds first place.
AI for Human! EClinCloud Leads a New "Patient-Centric" Era in Clinical ResearchEClinCloud launches a new era of AI 2.0, with comprehensive upgrades across its AI team, AI technology, and AI applications!
Congratulations to Trinomab on the Marketing Approval of Siltartoxatug! Supported by EClinCloud eCOAOn February 11, Xintituo® (generic name: siltartoxatug injection)—a world-first recombinant anti-tetanus toxin monoclonal antibody drug independently developed by Zhuhai Trinomab Pharmaceutical Co., Ltd. ("Trinomab")—was formally approved for marketing by China's National Medical Products Administration (NMPA). Notably, it is the world's first recombinant fully human monoclonal antibody in the field of tetanus prevention and will fundamentally change the current landscape of tetanus prevention, offering safer and more effective protection for patients worldwide.
Latest! "Guideline Variations" for Rheumatology Clinical Trials: From Draft for Comment to Final ReleaseRecently, the CDE officially released the "Technical Guidelines for the Use of Patient-Reported Outcomes in Clinical Trials of Rheumatic Diseases"[1]. Following a year and a half of rigorous preparation since its draft for comment was issued in June 2023, the guideline finally made its major debut in early 2025.
Happy Lantern Festival | EClinCloud Wishes You Every Fulfillment and Continued Good Fortune!EClinCloud published "Happy Lantern Festival | EClinCloud Wishes You Every Fulfillment and Continued Good Fortune!" on 2025-02-12. See this article for the full text and images.
Auspicious Year of the Snake: EClinCloud Wishes You a Happy New Year!EClinCloud published "Auspicious Year of the Snake: EClinCloud Wishes You a Happy New Year!" on 2025-01-28. See this article for the full text and accompanying images.